about
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test.The metabolism and transport of 1,5-anhydroglucitol in cells.Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population.Glycaemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetesThe association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patientsImpact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetesYin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFβ1Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischaemic heart diseaseThe association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetesContribution of structured self-monitoring of blood glucose to self-efficacy in poorly controlled diabetes patients in China1,5-Anhydroglucitol × glycated hemoglobin A1c/100 as a potential biomarker for islet β-cell function among patients with type 2 diabetesMaternal glycemic parameters and adverse pregnancy outcomes among high-risk pregnant womenFulminant type 1 diabetes: The clinical and continuous glucose monitoring characteristics in Chinese patientsEffectiveness of Smartphone App-Based Interactive Management on Glycemic Control in Chinese Patients With Poorly Controlled Diabetes: Randomized Controlled TrialSerum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes MellitusComparison of Multiple Cut Points for Time in Range in Relation to Risk of Abnormal Carotid Intima-Media Thickness and Diabetic Retinopathy
P50
Q33805419-6E95CF99-104D-48F3-9632-E41C1BA94559Q47115413-F27458B4-B3E3-4DDD-B4C9-C5391C80F15CQ48274733-9D669940-45E9-49C7-A752-05A0F08B1F83Q55359935-7F5F888E-D5CA-4465-9441-0DEAFF88C899Q57284576-D290BFD3-5FDF-4F20-85AA-A918F404A66BQ88161617-721D5604-CDFD-4A51-A763-CA94B612DC92Q89477060-BD5BC53F-4DFC-42A7-93FF-7C9D2A24C8FEQ90167631-C7084C1F-BE04-47DD-A720-693D2494F499Q90290631-3D5A340A-D152-4F61-93BD-F8480D35A8E0Q90718919-39E5E0BF-77A2-4E98-8304-733BEB707080Q91136679-F9BBE3E7-7FBA-476F-B17F-51A7D344382DQ91289492-9CA4CD0E-7CC1-4E6F-9981-A3B51DF4CC87Q91673001-56D4E3BA-F54E-4C0C-B619-C11C8AE504D8Q91730175-0CBCD20C-6FB6-4D3E-8F45-67026B2C1FFDQ91798246-22681D94-6A88-4006-9607-2E1FBE2B249DQ91844319-51A32DFC-A542-4269-9898-921B35943368Q96301505-ABCA9B70-1268-4754-91D0-34AA28DD813B
P50
description
researcher (ORCID 0000-0002-1534-2279)
@en
name
Jian Zhou
@en
type
label
Jian Zhou
@en
prefLabel
Jian Zhou
@en
P31
P496
0000-0002-1534-2279